Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
11/01/17 8-K Current report filing
Documents
6
10/24/17 8-K Current report filing
Documents
5
10/23/17 EFFECT Notice of Effectiveness 1
10/17/17 POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
Documents
22
10/05/17 4 Statement of changes in beneficial ownership of securities 1
10/05/17 4 Statement of changes in beneficial ownership of securities 1
10/05/17 4 Statement of changes in beneficial ownership of securities 1
10/04/17 8-K Current report filing 3
09/26/17 8-K Current report filing
Documents
5
09/15/17 424B5 Prospectus filed pursuant to Rule 424(b)(5) 31
RSS